Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Ashfield UK makes two new business development appointments

Ashfield UK makes two new business development appointments He also successfully launched and managed a direct competitor to Botox having joined the business at the beginning of September.

Teva buys Allergan generics unit for $40.5bn

Teva buys Allergan generics unit for $40.5bn Will now drop its six-month pursuit of Mylan.  . The world's largest generic drug manufacturer Teva has bought Botox-maker Allgeran's copycat medicines unit for more than $40bn. ... Allergan will as a result own around 10% of Teva, while in return the

Pharma deals in June 2015

Pharma deals in June 2015 Kythera has a portfolio of novel prescription products for the aesthetic medicine market which complement Allergan's facial aesthetics portfolio, including Botox.

Are you happy now?

Are you happy now? The plastic surgeries, the dermatology centres (Botox), the laser-vision correction centres are all excellent analogs for policymakers to look at for a real-world litmus test of what patient satisfaction

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera

Allergan inks $2.1bn deal to buy cosmetic drug firm Kythera Botox manufacturer Allergan has extended its position in the growing cosmetic or 'aesthetic' pharmaceuticals sector with the purchase, which adds Kythera's double chin therapy Kybella to its portfolio. . ... sales channels already in place for wrinkle

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics